［1］Rigante D. Clinical overview of vasculitic syndromes in the pediatric age ［J］. Eur Rev Med Pharmacol Sci, 2006, 10(6):337-345.
［2］Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy?［J］. Clin Exp Immunol, 1998, 114(3):468-476.
［3］Rauta V, Teppo AM, Tornroth T, Honkanen E, Riska CG. Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schonlein nephritis［J］.Nephrol Dial Transplant, 2003, 18(9):1785-1791.
［4］刘雪梅，邹敏书，余健,聂国明.过敏性紫癜肾炎及IgA肾炎患儿尿液IL-1β和MCP-1检测的意义［J］.华南国防医学杂志，2006，20(5):15-17.
［5］Hirayama K, Kobayashi M, Muro K, Yoh K, Yamagata K, Koyama A.Specific T-cell receptor usage with cytokinemia in Henoch-Schonlein purpura nephritis associated with Staphylococcus aureus infection［J］. J Intern Med, 2001, 249(4):289-295.
［6］Kawasaki Y, Suzuki J, Sakai N, Isome M, Nozawa R, Tanji M, et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis［J］. Am J Kidney Dis, 2004, 44(1):42-49.
［7］顾晓红，陈荣华，梅柏如，黄文彦，黄松明.过敏性紫癜患儿的免疫功能测定及意义［J］.南京医科大学学报，2003，23（6）：591-594.
［8］Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis［J］. Nephrol Dial Transplant, 2004, 19(1):8-11.
［9］Watts RA, Scott DG. Epidemiology of vasculities［J］. Curr Opin Rheumatol, 2003, 15 (1):11-16.
［10］Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schonlein, purpura［J］. Pediatr Nephrol, 2005, 20(2):149-153.
［11］潘凯丽，白庆峰，黄莹，李琦.过敏性紫癜患儿血清白细胞介素-4、-6、-8及肿瘤坏死因子-α表达的意义［J］.实用儿科临床杂志， 2007， 22(21):1632-1633.
［12］刘磊，江捍平，王兵.IL10在过敏性紫癜血管内皮细胞损伤中的作用机制研究［J］.小儿急救医学，2004，11(4):225-227.
［13］Saura M, Martinez DR, Minty A, Perez SD, Lamas S. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells［J］.Biochem J, 1996, 313(2):641-646.
［14］Kohno M, Tsutsumi A, Matsui H, Sugihara M, Suzuki T, Mamura M, et al. Interleukin-17 gene expression in patients with rheumatoid arthritis［J］．Mod Rheumatol, 2008, 18(1):15-22.
［15］陈谱，何韶衡，陈穗.过敏性紫癜患儿血浆白细胞介素-17、-10、-4及干扰素-γ水平的临床意义［J］. 实用儿科临床杂志, 2004, 19(11):969-970.
［16］Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, et al. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis［J］．Eur J Immunol, 2006, 36(11):2857-2867.
［17］孙大庆，张秋业，董增义，白枫. 过敏性紫癜病儿树突细胞分泌自细胞介素12水平与TH1/TH2的变化［J］.中国当代儿科杂志, 2006, 8(4):307-310.
［18］Topaloglu R, Sungur A, Baskin E, Besbas N, Saatci U, Bakkaloglu A.Vascular endothelial growth factor in Henoch-Schonlein purpura［J］. J Rheumatol, 2001, 28(10):2269-2273.
［19］Nishida M, Kawakatsu H, Ishiwari K, Tamai M, Sawada T, Nishimura M, et al. Serum hepatocyte growth factor levels in patients with renal diseases［J］. Am J Nephrol, 1999, 19(4):509-512.